Lineage Cell Therapeutics... (LCTX)
Lineage Cell Therapeutics Max Pain By Strike
LCTX trades at $1.67, 11.3% above the near-term max pain of $1.5 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($0.5-$90), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Lineage Cell Therapeutics Max Pain By Expiry
Max pain for LCTX shows a downward trend from 90 to 0.5, indicating bearish sentiment or hedging activity. The 481% spread signals divergent expectations across timeframes. Most levels below 1.67 may cap rallies. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
Expiration Date | Max Pain | Max Pain vs Current Price |
---|---|---|
Oct 17, 2025 | 1.5 | n/a (n/a) |
Nov 21, 2025 | 0.5 | n/a (n/a) |
Dec 19, 2025 | 0.5 | n/a (n/a) |
Jan 16, 2026 | 90 | n/a (n/a) |
Mar 20, 2026 | 0.5 | n/a (n/a) |